These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6715123)

  • 1. Effects of L-carnitine on adriamycin-induced cardiomyopathy in rabbit.
    Paterna S; Furitano G; Scaffidi L; Barbarino C; Campisi D; Parisi G; Carreca I
    Int J Tissue React; 1984; 6(1):91-5. PubMed ID: 6715123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of HSP70 and ultrastructure of heart and liver tissues of rats treated with adriamycin: protective role of L-carnitine.
    Strauss M; Porras N
    Invest Clin; 2007 Mar; 48(1):33-43. PubMed ID: 17432542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection from adriamycin-induced cardiomyopathy in rats.
    Shug AL
    Z Kardiol; 1987; 76 Suppl 5():46-52. PubMed ID: 3433883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine protection against adriamycin-induced cardiomyopathy in rats.
    McFalls EO; Paulson DJ; Gilbert EF; Shug AL
    Life Sci; 1986 Feb; 38(6):497-505. PubMed ID: 3945174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of carnitine to prevent adriamycin cardiomyopathy.
    Goldsmith MA; Suzuki Y; Ohnuma T; Holland JF
    Cancer Treat Rep; 1979 Apr; 63(4):558-60. PubMed ID: 445512
    [No Abstract]   [Full Text] [Related]  

  • 6. Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy.
    Sayed-Ahmed MM; Salman TM; Gaballah HE; Abou El-Naga SA; Nicolai R; Calvani M
    Pharmacol Res; 2001 Jun; 43(6):513-20. PubMed ID: 11419959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of adriamycin-induced cardiotoxicity by selenium in rabbits.
    Dimitrov NV; Hay MB; Siew S; Hudler DA; Charamella LJ; Ullrey DE
    Am J Pathol; 1987 Feb; 126(2):376-83. PubMed ID: 3826299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine promotes heat shock protein synthesis in adriamycin-induced cardiomyopathy in a neonatal rat experimental model.
    Strauss M; Anselmi G; Hermoso T; Tejero F
    J Mol Cell Cardiol; 1998 Nov; 30(11):2319-25. PubMed ID: 9925368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory chain deficiency precedes the disrupted calcium homeostasis in chronic doxorubicin cardiomyopathy.
    Lebrecht D; Kirschner J; Geist A; Haberstroh J; Walker UA
    Cardiovasc Pathol; 2010; 19(5):e167-74. PubMed ID: 19747854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed and progressive myocardial lesions after adriamycin administration in the rabbit.
    Jaenke RS
    Cancer Res; 1976 Aug; 36(8):2958-66. PubMed ID: 1277204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of L-carnitine on cardiac metabolic damage induced by doxorubicin in vitro.
    Neri B; Cini-Neri G; Bartalucci S; Bandinelli M
    Anticancer Res; 1986; 6(4):659-62. PubMed ID: 3752946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of doxorubicin cardiotoxicity by carnitine is specific of the L-diasteroisomer.
    Maccari F; Ramacci MT
    Biomedicine; 1981 May; 35(2):65-7. PubMed ID: 7260239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
    Xiang P; Deng HY; Li K; Huang GY; Chen Y; Tu L; Ng PC; Pong NH; Zhao H; Zhang L; Sung RY
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adriamycin-induced cardiomyopathy. A rat model.
    Czarnecki A; Hinek A; Sołtysiak-Pawluczuk D
    Pol J Pharmacol Pharm; 1986; 38(2):171-7. PubMed ID: 3748888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice.
    Yen HC; Oberley TD; Gairola CG; Szweda LI; St Clair DK
    Arch Biochem Biophys; 1999 Feb; 362(1):59-66. PubMed ID: 9917329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential long-term subcellular responses in heart and liver to adriamycin stress. Exogenous L-carnitine cardiac and hepatic protection.
    Zeidán Q; Strauss M; Porras N; Anselmi G
    J Submicrosc Cytol Pathol; 2002 Jul; 34(3):315-21. PubMed ID: 12408365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vivo animal model to study chronic adriamycin cardiotoxicity: a P-31 nuclear magnetic resonance spectroscopy investigation.
    Thompson RT; Marsh GD; Butland T; Sprague C; Sanford SE; Peemoeller H; Driedger AA; Inch WR
    In Vivo; 1991; 5(1):13-6. PubMed ID: 1932618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
    Tesoriere L; Ciaccio M; Valenza M; Bongiorno A; Maresi E; Albiero R; Livrea MA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):430-6. PubMed ID: 8169849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emetine-induced cardiomyopathy in rabbits.
    Khan MY; Haider B; Thind IS
    J Submicrosc Cytol; 1983 Apr; 15(2):495-507. PubMed ID: 6133959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute adriamycin cardiotoxicity: morphologic alterations in isolated perfused rabbit heart.
    Taylor AL; Bulkley BH
    Lab Invest; 1982 Nov; 47(5):459-64. PubMed ID: 7132289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.